Schedule 13G ownership disclosure

Tarsus Pharmaceuticals Inc

Common Stock, $0.0001 par value per share · CUSIP: 87650L103

Event date: 2024-12-31

Filing-level shares
1,909,228
Percent of class
4.9%
  • Cowen Financial Products LLC

    Shares: 1,909,228 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-25-001215
Form type
SCHEDULE 13G/A
Filer
Cowen Financial Products LLC
CIK
CIK 1771015
Filed
Feb 13, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub